ROTAVAC 5D

BIOLOGICAL3 trials

Sponsors

Centre for Infectious Disease Research in Zambia, University of Chile, Bharat Biotech International Limited

Conditions

DiarrheaDiarrhea RotavirusRotavirus GastroenteritisRotavirus Infection of Children

Phase 2

Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia

CompletedNCT03602053

Centre for Infectious Disease Research in ZambiaDiarrhea, Diarrhea Rotavirus

Start: 2019-01-22End: 2019-10-04Updated: 2020-12-19

Phase 3

The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E

University of ChileRotavirus Gastroenteritis

Start: 2023-07-06End: 2025-06-01Target: 5800Updated: 2023-07-25

The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants

Active, not recruitingNCT06200844

Bharat Biotech International LimitedRotavirus Infection of Children

Start: 2023-07-07End: 2026-07-31Target: 5800Updated: 2025-05-22